Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: Implications of low-responsiveness to bacterial components in the epidermal Langerhans cells

Biochemical and Biophysical Research Communications

Volumn 306, Issue 3, 2003, Pages 674-679

  Takeuchi, Junko ^a   Watari, Eiji ^a   Shinya, Eiji ^a   Norose, Yoshihiko ^a   Matsumoto, Misako ^b   Seya, Tsukasa ^b   Sugita, Masahiko ^a   Kawana, Seiji ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Dendritic cells; Langerhans cells; Lipopolysaccharide; Peptidoglycan; Toll like receptor; Transforming growth factor 1

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 14; LIGAND; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; CELL SURFACE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EPIDERMIS CELL; EXPOSURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LANGERHANS CELL; LANGERHANS CELL LIKE DENDRITIC CELL; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BACTERIUM; CELL CULTURE; CELL GRANULE; CELL SIZE; CYTOLOGY; DRUG EFFECT; EPIDERMIS; GENETICS; IMMUNOLOGY; METABOLISM; PHENOTYPE;

BACTERIA (MICROORGANISMS);

ANTIGENS, CD14; BACTERIA; CELL SIZE; CELLS, CULTURED; CYTOPLASMIC GRANULES; DOWN-REGULATION; EPIDERMIS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LANGERHANS CELLS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PEPTIDOGLYCAN; PHENOTYPE; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0043133473     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01022-2     Document Type: Article

References (33)

1. Wolff K., Stingl G. The Langerhans cell. J. Invest. Dermatol. 80:1983;17s-21s.
2. Stingl G., Maurer D., Hauser C., Wolff K. The epidermis: an immunologic microenvironment. Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.I., Fitzpatrick T.B. Fitzpatrick's Dermatology in General Medicine. 1999;343-370 McGraw-Hill, New York.
3. Geissmann F., Prost C., Monnet J.P., Dy M., Brousse N., Hermine O. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187:1998;961-966.
4. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109-1118.
5. Kaisho T., Akira S. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta. 1589:2002;1-13.
6. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;3388-3393.
7. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869.
8. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2001;135-145.
9. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
10. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
11. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll- like receptor 3. Nature. 413:2001;732-738.
12. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
13. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
14. Vogel S.N., Johnson D., Perera P.Y., Medvedev A., Lariviere L., Qureshi S.T., Malo D. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:1999;5666-5670.
15. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
16. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., Amigorena S., Hermine O., Durandy A. TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:1999;4567-4575.
17. Chiller K., Selkin B.A., Murakawa G.J. Skin microflora and bacterial infections of the skin. J. Invest. Dermatol. Symp. Proc. 6:2001;170-174.
18. Fredricks D.N. Microbial ecology of human skin in health and disease. J. Invest. Dermatol. Symposium Proceedings. 6:2001;167-169.
19. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seya T. T, Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:2002;1364-1369.
20. Pena-Cruz V., Ito S., Oukka M., Yoneda K., Dascher C.C., Von Lichtenberg F., Sugita M. Extraction of human Langerhans cells: a method for isolation of epidermis-resident dendritic cells. J. Immunol. Methods. 255:2001;83-91.
21. Sugita M., Porcelli S.A., Brenner M.B. Assembly and retention of CD1b heavy chains in the endoplasmic reticulum. J. Immunol. 159:1997;2358-2365.
22. Kashihara M., Ueda M., Horiguchi Y., Furukawa F., Hanaoka M., Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J. Invest. Dermatol. 87:1986;602-607.
23. Valladeau J., Ravel O., Dezutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., Duvert-Frances V., Vincent C., Schmitt D., Davoust J., Caux C., Lebecque S., Saeland S. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12:2000;71-81.
24. Strobl H., Knapp W. TGF-β1 regulation of dendritic cells. Microbes & Infection. 1:1999;1283-1290.
25. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:2000;199-205.
26. Biron C.A. Interferons α and β as immune regulators-a new look. Immunity. 14:2001;661-664.
27. Merad M., Manz M.G., Karsunky H., Wagers A., Peters W., Charo I., Weissman I.L., Cyster J.G., Engleman E.G. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:2002;1135-1141.
28. Geissmann F., Dieu-Nosjean M.C., Dezutter C., Valladeau J., Kayal S., Leborgne M., Brousse N., Saeland S., Davoust J. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196:2002;417-430.
29. Borkowski T.A., Letterio J.J., Farr A.G., Udey M.C. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:1996;2417-2422.
30. Borkowski T.A., Letterio J.J., Mackall C.L., Saitoh A., Wang X.J., Roop D.R., Gress R.E., Udey M.C. A role for TGF-β1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGF-β1 null mice. J. Clin. Invest. 100:1997;575-581.
31. Akhurst R.J.F.F., Balmain A. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature. 331:1988;363-365.
32. Hashimoto K. Regulation of keratinocyte function by growth factors. J. Dermatol. Sci. 24:2000;S46-50.
33. Amagai M., Matsuyoshi N., Wang Z.H., Andl C., Stanley J.R. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat. Med. 6:2000;1275-1277.